GLOW is a multi-peptide research blend combining GHK-Cu, BPC-157 and TB-500 in a single lyophilised formulation. The combination brings together three compounds being investigated for their roles in tissue remodelling, cellular repair pathways, extracellular matrix activity and skin-related research.

What is GLOW?

GLOW combines three research peptides with different areas of scientific interest:

GHK-Cu
A naturally occurring copper-binding tripeptide extensively studied in relation to skin biology, collagen production, extracellular matrix remodelling, antioxidant pathways and cellular signalling.

BPC-157
A synthetic 15-amino-acid peptide primarily investigated in preclinical research involving tissue repair, angiogenesis, connective tissue, gastrointestinal protection and inflammatory pathways.

TB-500
A synthetic peptide related to thymosin beta-4 research. It is primarily investigated for its relationship with actin regulation, cell migration, angiogenesis and tissue-remodelling processes.

Why Combine Them?

The concept behind the GLOW blend is to investigate several complementary biological pathways within a single research formulation.

GHK-Cu is predominantly associated with collagen and extracellular-matrix research, while BPC-157 is studied for tissue-repair and angiogenic pathways, and TB-500-related research focuses heavily on cell migration and tissue remodelling.

This combination has therefore become particularly interesting for research involving:

• Skin and extracellular matrix biology
• Collagen-related pathways
• Tissue regeneration and remodelling
• Fibroblast activity
• Angiogenesis
• Cellular migration
• Connective-tissue research
• Oxidative-stress and inflammatory signalling

GLOW 70mg

A commonly used 70mg GLOW formulation contains:

GHK-Cu – 50mg
BPC-157 – 10mg
TB-500 – 10mg

Total peptide content: 70mg